{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:10:51Z","timestamp":1786119051103,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/crd.0b013e31818adc50","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T03:29:39Z","timestamp":1229398179000},"page":"31-35","source":"Crossref","is-referenced-by-count":25,"title":["Fabry Disease"],"prefix":"10.1097","volume":"17","author":[{"given":"Bredy","family":"Pierre-Louis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210203","first-page":"3733","article-title":"The Metabolic Bases of Inherited Disease. 8th ed.","author":"Desnick","year":"2001"},{"key":"R2-5-20210203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.1380030204","article-title":"Molecular basis of Fabry disease. Mutations and polymorphisms in the human alpha-galactosidase A gene.","volume":"3","author":"Eng","year":"1994","journal-title":"Hum Mutat"},{"key":"R3-5-20210203","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-146-6-200703200-00007","article-title":"Narrative review: Fabry disease.","volume":"146","author":"Clarke","year":"2007","journal-title":"Ann Intern Med"},{"key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1651-2227.2002.tb03104.x","article-title":"Cardiac involvement in Fabry disease.","volume":"91","author":"Linhart","year":"2002","journal-title":"Acta Paediatr Suppl"},{"key":"R5-5-20210203","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders.","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy.","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males.","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/01.CIR.0000061952.27445.A0","article-title":"Early detection of Fabry cardiomyopathy by tissue Doppler imaging.","volume":"107","author":"Pieroni","year":"2003","journal-title":"Circulation"},{"key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606034","article-title":"Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy.","volume":"417","author":"Elleder","year":"1990","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"R10-5-20210203","first-page":"469","article-title":"Cardiac variant of Fabry's disease mimicking hypertrophic cardiomyopathy.","volume":"44","author":"Chimenti","year":"1999","journal-title":"Cardiologia"},{"key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry's disease with manifestations confined to the myocardium.","volume":"324","author":"von Scheidt","year":"1991","journal-title":"N Engl J Med"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy.","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"R13-5-20210203","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"R14-5-20210203","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-0736(82)80010-1","article-title":"Electrocardiograms in Fabry's disease.","volume":"15","author":"Sheth","year":"1982","journal-title":"J Electrocardiol"},{"key":"R15-5-20210203","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0002-8703(90)90096-G","article-title":"Combined atrioventricular block and sinus node dysfunction in Fabry's disease.","volume":"120","author":"Suzuki","year":"1990","journal-title":"Am Heart J"},{"key":"R16-5-20210203","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000047318","article-title":"Ventricular fibrillation refractory to automatic internal cardiac defibrillator in Fabry's disease. Review of cardiovascular manifestations.","volume":"94","author":"Eckart","year":"2000","journal-title":"Cardiology"},{"key":"R17-5-20210203","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijcard.2005.08.023","article-title":"Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.","volume":"111","author":"Hoigne","year":"2006","journal-title":"Int J Cardiol"},{"key":"R18-5-20210203","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy.","volume":"110","author":"Chimenti","year":"2004","journal-title":"Circulation"},{"key":"R19-5-20210203","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jacc.2005.11.070","article-title":"Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization.","volume":"47","author":"Pieroni","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R20-5-20210203","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2214\/AJR.05.0442","article-title":"MRI characterization of myocardial tissue in patients with Fabry's disease.","volume":"188","author":"Imbriaco","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"R21-5-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial.","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann Intern Med"},{"key":"R22-5-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"International Collaborative Fabry Disease Study Group. Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabrys disease.","volume":"345","author":"Eng","year":"2001","journal-title":"N Eng J Med"},{"key":"R23-5-20210203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long term safety and efficacy of enzyme replacement therapy for Fabrys disease.","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R24-5-20210203","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mus.10497","article-title":"Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.","volume":"28","author":"Schiffmann","year":"2003","journal-title":"Muscle Nerve"},{"key":"R25-5-20210203","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1651-2227.2003.tb00214.x","article-title":"Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data.","volume":"92","author":"Dehout","year":"2003","journal-title":"Acta Paediatr Suppl"},{"key":"R26-5-20210203","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1523-1755.2004.00514.x","article-title":"Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study.","volume":"65","author":"Mignani","year":"2004","journal-title":"Kidney Int"},{"key":"R27-5-20210203","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1023\/B:BOLI.0000005658.14563.77","article-title":"Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study.","volume":"26","author":"Baehner","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"R28-5-20210203","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.amjcard.2005.11.087","article-title":"Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy.","volume":"97","author":"Beer","year":"2006","journal-title":"Am J Cardiol"},{"key":"R29-5-20210203","first-page":"357","article-title":"Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase.","volume":"92","author":"Elliott","year":"2006","journal-title":"Am Heart J"},{"key":"R30-5-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","article-title":"Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy.","volume":"345","author":"Frustaci","year":"2001","journal-title":"N Engl J Med"},{"key":"R31-5-20210203","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1272\/jnms.72.254","article-title":"Cardiovascular manifestations of Fabry disease and the novel therapeutic strategies.","volume":"72","author":"Seino","year":"2005","journal-title":"J Nippon Med Sch"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0b013e31818adc50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:27:12Z","timestamp":1786037232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045415-200901000-00005"}},"subtitle":["Cardiac Manifestations and Therapeutic Options"],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0b013e31818adc50","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}